Cargando…

ACRODAT® and AcroVoice: an insight into a holistic approach to the management of acromegaly

Detalles Bibliográficos
Autores principales:	Lundie, Mark, Sisco, Jill, van der Lely, Aart J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842384/ https://www.ncbi.nlm.nih.gov/pubmed/31598813 http://dx.doi.org/10.1007/s11102-019-00994-4

Ejemplares similares

AcroVoice: eliciting the patients’ perspective on acromegaly disease activity
por: Jackson, Yanina, et al.
Publicado: (2019)

Development of ACRODAT(®), a new software medical device to assess disease activity in patients with acromegaly
por: van der Lely, Aart J., et al.
Publicado: (2017)

Towards an Earlier Diagnosis of Acromegaly and Gigantism
por: Sisco, Jill, et al.
Publicado: (2021)

Development of a novel patient-reported measure for acromegaly: the Acro-TSQ
por: Fleseriu, Maria, et al.
Publicado: (2019)

SAT-LB078 Acromegaly Disease Activity According to ACRODAT® in Spain: ACROVAL Study
por: Marazuela, Monica, et al.
Publicado: (2019)

Acromegaly disease activity according to ACRODAT®, a cross-sectional study in Spain: ACROVAL study
por: Marazuela, Mónica, et al.
Publicado: (2021)

Acromegaly Quality of Life Questionnaire (AcroQoL)
por: Badia, Xavier, et al.
Publicado: (2004)

An evaluation of the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) in adult patients with acromegaly, including correlations with other patient-reported outcome measures: data from two large multicenter international studies
por: Fleseriu, Maria, et al.
Publicado: (2020)

Pregnancy and acromegaly
por: Muhammad, Ammar, et al.
Publicado: (2016)

Approach to the Patient With Treatment-resistant Acromegaly
por: Coopmans, Eva C, et al.
Publicado: (2022)

Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study
por: Caron, Philippe, et al.
Publicado: (2018)

Validation of Acromegaly Quality of Life Questionnaire (AcroQoL) for the Iranian population
por: Danaei, Mina, et al.
Publicado: (2022)

Pegvisomant for acromegaly: does it always works?
por: Neggers, Sebastian J., et al.
Publicado: (2019)

Correction to: Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study
por: Caron, Philippe, et al.
Publicado: (2018)

Acro-osteolysis
por: Thomas, Joe, et al.
Publicado: (2019)

The position of combined medical treatment in acromegaly
por: Coopmans, Eva C., et al.
Publicado: (2019)

Risk factors and management of pasireotide-associated hyperglycemia in acromegaly
por: Gadelha, Mônica R, et al.
Publicado: (2020)

Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea
por: Chin, Sang Ouk, et al.
Publicado: (2015)

Improved AcroQoL scores in acromegaly after sagittal split ramus osteotomy with Le Fort I osteotomy
por: Taguchi, Tomomi, et al.
Publicado: (2021)

Acro-cardio-facial syndrome
por: Digilio, Maria Cristina, et al.
Publicado: (2010)

Acro-osteolysis & calcinosis in scleroderma
por: Cherian, Sujith V., et al.
Publicado: (2016)

Clinical Image: Acro‐osteolysis
por: Chatterjee, Soumya
Publicado: (2019)

THU055 The Acro-TIME Score: A New Clinical, Pathological And Immune Integrative Approach To Early Identify Acromegaly Patients Resistant To Treatment With First Generation Somatostatin Ligands
por: Chiloiro, Sabrina, et al.
Publicado: (2023)

A Pituitary Society update to acromegaly management guidelines
por: Fleseriu, Maria, et al.
Publicado: (2020)

Acro-callous syndrome: A case report
por: Lamrissi, A., et al.
Publicado: (2022)

Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy
por: Brue, Thierry, et al.
Publicado: (2018)

Hypertension in Acromegaly in Relationship to Biochemical Control and Mortality: Global ACROSTUDY Outcomes
por: Vila, Greisa, et al.
Publicado: (2020)

Combined treatment of somatostatin analogues with pegvisomant in acromegaly
por: Franck, S. E., et al.
Publicado: (2015)

Band acro-osteolysis in a middle-aged woman
por: Uchiyama, Toru
Publicado: (2019)

Dermatologic Manifestation of Acro-Ischemia Associated With COVID-19
por: Gumbita, Robert, et al.
Publicado: (2022)

Soluble Klotho: a possible predictor of quality of life in acromegaly patients
por: Coopmans, Eva C., et al.
Publicado: (2020)

Normas y especificaciones de tubería de acro inoxidable /
por: Gómez Rosas, Fabricio Orlando
Publicado: (2012)

Acro-osteolysis and calcinosis in patient with scleroderma: A case report
por: Choi, Wan-Sun, et al.
Publicado: (2017)

Severe Acro-osteolysis in a Case of Limited Cutaneous Scleroderma
por: HOSSEINIALHASHEMI, Milad, et al.
Publicado: (2017)

Scleroderma with Acro-Osteolysis and Papular Mucinosis Resembling Multicentric Reticulohistiocytosis
por: Dantas, João, et al.
Publicado: (2020)

More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY
por: Fleseriu, Maria, et al.
Publicado: (2021)

Management of acromegaly
por: Vasilev, Vladimir, et al.
Publicado: (2010)

Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider
por: Geer, Eliza B., et al.
Publicado: (2019)

ODP353 Sustained Suppression of IGF1 with AZP-3813, a Bicyclic 16-Amino Acid Peptide Antagonist of the Human Growth Hormone Receptor and a Potential New Treatment for Acromegaly
por: Culler, Michael, et al.
Publicado: (2022)

A holistic approach to the mycetoma management
por: Bakhiet, Sahar Mubarak, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j89d0nv5uc7bb747rlmt169k7a